Are Zucker obese rats a useful model for cardiovascular complications in metabolic syndrome? Physical- biochemical and oxidative stress considerations-

Authors
R. Debin, B. Lauzier, P. Sicard, S. Delemasure, S. Amoureux et al.

Lab
Facultés de Médecine et de Pharmacie, Laboratoire de Physiopathologie et Pharmacologie Cardio-vasculaires Expérimentales, Dijon, France.

Journal
Fundamental and Clinical Pharmacology

Abstract
We wondered if Zucker obese (ZO) rats would be a good experimental model to evaluate cardiovascular complications of metabolic syndrome (MS). ZO rats were compared with both their littermate controls, Zucker lean (ZL) rats and to Wistar rats (reference strain). We designed this work:(i) to measure certain physical and biochemical characteristics of MS; (ii) to evaluate coronary and cardiac function in isolated conditions and after ischemia; and (iii) to study plasma and heart tissue oxidative stress markers. In vivo, ZO rats had higher levels of plasma glucose, cholesterol and triglycerides than their ZL littermates, but there was no difference between the groups for systolic arterial blood pressure and heart rate. In vitro, coronary endothelial function was notably impaired in ZO and ZL rats. After global ischemia, the worse ventricular recovery in ZO and ZL rats was associated with arrhythmias during reperfusion. We detected similar levels of plasma ascorbyle free radical, oxygen radical absorbance capacity and vitamin C concentrations in the three groups. Dihydroethidium staining showed higher superoxide production in the coronary vessels of ZO rats than in ZL and Wistar rats. Our results show that ZO might only correspond to early-stage cardiovascular complications associated with MS.

BIOSEB Instruments Used:
Non Invasive Pressure Measurement (LE5001),Cuffs and pulse transducers for LE 500X indirect blood pressure meters (LE5012)